EMA Considers Cardiovascular Indication & Extra Market Protection For Wegovy

 
• By Neena Brizmohun
  
Wegovy has been shown to reduce the risk of major adverse cardiovascular events • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography